These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11956544)
1. Neck mass as primary manifestation of multiple myeloma originating in the thyroid cartilage. Gross M; Eliashar R; Petrova P; Goldfarb A; Sichel JY Otolaryngol Head Neck Surg; 2002 Mar; 126(3):326-8. PubMed ID: 11956544 [No Abstract] [Full Text] [Related]
2. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma. Piccinini L; Artusi T; Bonacorsi G; Arigliano V Haematologica; 2002 Feb; 87(2):EIM04. PubMed ID: 11836178 [No Abstract] [Full Text] [Related]
3. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol]. Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860 [No Abstract] [Full Text] [Related]
6. A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma. Hönemann D; Prince HM; Seymour JF; Wolf MM; Westerman D; Januszewicz EH Leuk Lymphoma; 2005 Jun; 46(6):945-7. PubMed ID: 16019544 [No Abstract] [Full Text] [Related]
7. Alternating combination of alkylating agents and vincristine, doxorubicin, and dexamethasone in multiple myeloma. Lejeune C; Sotto JJ; Fuzibet JG; Rossi JF; Lepeu G; Bataille R J Clin Oncol; 1991 Jun; 9(6):1090-1. PubMed ID: 2033423 [No Abstract] [Full Text] [Related]
8. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation. Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010 [No Abstract] [Full Text] [Related]
10. Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma. Rostagno C; Ciolli S Ann Hematol; 2006 Sep; 85(9):627-8. PubMed ID: 16705455 [No Abstract] [Full Text] [Related]
11. Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide. Chim CS; Choi PT; Lee WK Ann Hematol; 2013 Jun; 92(6):855-7. PubMed ID: 23183880 [No Abstract] [Full Text] [Related]
12. [Pneumonia caused by Salmonella in a patient with myeloma]. Fernández P; Roldán V; García MC; Gil MT; Rivas C Sangre (Barc); 1995 Jun; 40(3):234-5. PubMed ID: 7570286 [No Abstract] [Full Text] [Related]
13. Chemotherapy of resistant multiple myeloma with vincristine, adriamycin and dexamethasone (VAD). Maniatis A; Stamatellou M; Papanastasiou K Chemioterapia; 1987 Jun; 6(2 Suppl):727-8. PubMed ID: 3509532 [No Abstract] [Full Text] [Related]
14. Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112. Chou T; Tobinai K; Uike N; Asakawa T; Saito I; Fukuda H; Mizoroki F; Ando K; Iida S; Ueda R; Tsukasaki K; Hotta T; Jpn J Clin Oncol; 2011 Apr; 41(4):586-9. PubMed ID: 21247967 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of multiple myeloma--associated amyloidosis by interferon-alpha, dimethyl sulfoxide, and VAD (vincristine, adriamycin, and dexamethasone). Ichida M; Imagawa S; Ohmine K; Komatsu N; Hatake K; Ozawa K; Miura Y Int J Hematol; 2000 Dec; 72(4):491-3. PubMed ID: 11197218 [TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with vincristine, doxorubicin, dexamethasone for refractory or relapsing multiple myeloma. Monconduit M; Le Loet X; Bernard JF; Michaux JL Br J Haematol; 1986 Jul; 63(3):599-601. PubMed ID: 3730288 [No Abstract] [Full Text] [Related]
17. [Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion]. Monconduit M; Le Loët X; Bernard JF; Menard JF; Grosbois B; Michaux JL; De Gramont A; Laporte JP; Najman A; Jouet JP Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):477-9. PubMed ID: 3616472 [No Abstract] [Full Text] [Related]
18. High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma. van der Spek E; Bloem AC; Sinnige HA; Lokhorst HM Haematologica; 2007 Dec; 92(12):e130-1. PubMed ID: 18055977 [TBL] [Abstract][Full Text] [Related]
19. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol]. Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962 [TBL] [Abstract][Full Text] [Related]
20. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients? van Rhee F Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985 [No Abstract] [Full Text] [Related] [Next] [New Search]